3D Tumor Microenvironment Models

For preclinical screening and MOA

A new paradigm for preclinical screening by combining translational relevance with in vitro throughput for Oncology and IO therapies.

Cypre is a biotechnology company dedicated to working with therapeutic innovators to overcome drug resistance for cancer patients.

Used by top-10 pharmaceuticals, a multitude of biotechs, and leading academic centers, our 3D in vitro tumor microenvironment models allow our partners to rapidly screen and generate comprehensive insights into your therapeutic’s efficacy and mechanism of action.